Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality
Year of publication: |
2002-06
|
---|---|
Authors: | Nicholson, Sean ; Danzon, Patricia M. ; McCullough, Jeffrey S. |
Institutions: | National Bureau of Economic Research (NBER) |
Extent: | application/pdf |
---|---|
Series: | |
Type of publication: | Book / Working Paper |
Notes: | CF HC published as Sean Nicholson, 2005. "Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality," Journal of Business, University of Chicago Press, vol. 78(4), pages 1433-1464, July. Number 9007 |
Classification: | I11 - Analysis of Health Care Markets ; L24 - Contracting Out; Joint Ventures |
Source: |
-
Rent a Womb : Surrogate Selection, Investment Incentives and Contracting
Banerjee, Swapnendu, (2006)
-
Use and Abuse of Bargaining Models in Antitrust
Wright, Joshua D., (2020)
-
Tunneling and Hidden Profits in Health Care
Gandhi, Ashvin, (2024)
- More ...
-
Mergers and Acquisitions in the Pharmaceutical and Biotech Industries
Danzon, Patricia M., (2004)
-
Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances
Danzon, Patricia M., (2003)
-
Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality
Nicholson, Sean, (2002)
- More ...